Accès ouvert
2026
article
OpenAlex
Choong‐Hyun Koh, Yoosun Lee, Il‐Kyu Kim, Yeonseok Chung
The tumour microenvironment (TME) consists of a complex ecosystem of tumour cells, stromal elements, extracellular matrix, fibroblasts and diverse immune-cell populations. Although traditional cancer therapies have primarily focused on eliminating tumour cells, subsequent advances highlighted the importance of modulating immune cells within …
gb, kr
(code pays fourni par la source)
Accès ouvert
2025
supplementary-materials
OpenAlex
Eun‐Ah Bae, Hyungseok Seo, Byung Seok Kim, Jeongwon Choi et autres
Supplementary Figures
Accès ouvert
2025
other
OpenAlex
Eun‐Ah Bae, Hyungseok Seo, Byung Seok Kim, Jeongwon Choi et autres
Abstract PD-1–based cancer immunotherapy is a successful example of immune checkpoint blockade that provides long-term durable therapeutic effects in patients with cancer across a wide spectrum of cancer types. Accumulating evidence suggests that anti-PD-1 therapy enhances antitumor immunity by reversing the function …
Accès ouvert
2024
article
OpenAlex
Choong‐Hyun Koh, Byung‐Seok Kim, Chang‐Yuil Kang, Yeonseok Chung et autres
Studies over the last 2 decades have identified IL-17 and IL-21 as key cytokines in the modulation of a wide range of immune responses. IL-17 serves as a critical defender against bacterial and fungal pathogens, while maintaining symbiotic relationships with commensal microbiota. …
kr, Soudan
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Choong‐Hyun Koh, Suyoung Lee, Minkyeong Kwak, Byung‐Seok Kim et autres
CD8 T cells play crucial roles in immune surveillance and defense against infections and cancer. After encountering antigenic stimulation, naïve CD8 T cells differentiate and acquire effector functions, enabling them to eliminate infected or malignant cells. Traditionally, cytotoxic T cells, characterized by …
kr, pr
(code pays fourni par la source)
2023
article
OpenAlex
Da‐Sol Kuen, Jihye Hong, Suyoung Lee, Choong‐Hyun Koh et autres
Abstract To demonstrate potent efficacy, a cancer vaccine needs to activate both innate and adaptive immune cells. Personalized cancer vaccine strategies often require the identification of patient‐specific neoantigens; however, the clonal and mutational heterogeneity of cancer cells presents inherent challenges. Here, extracellular …
kr, Éthiopie, Soudan
(code pays fourni par la source)
Accès ouvert
2023
other
OpenAlex
Il‐Kyu Kim, Choong‐Hyun Koh, Insu Jeon, Kwangsoo Shin et autres
Abstract GM-CSF as an adjuvant has been shown to promote antitumor immunity in mice and humans; however, the underlying mechanism of GM-CSF–induced antitumor immunity remains incompletely understood. In this study, we demonstrate that GM-CSF potentiates the efficacy of cancer vaccines through IL9-producing …
Accès ouvert
2023
other
OpenAlex
Il‐Kyu Kim, Choong‐Hyun Koh, Insu Jeon, Kwangsoo Shin et autres
Abstract GM-CSF as an adjuvant has been shown to promote antitumor immunity in mice and humans; however, the underlying mechanism of GM-CSF–induced antitumor immunity remains incompletely understood. In this study, we demonstrate that GM-CSF potentiates the efficacy of cancer vaccines through IL9-producing …
Accès ouvert
2023
supplementary-materials
OpenAlex
Il‐Kyu Kim, Choong‐Hyun Koh, Insu Jeon, Kwangsoo Shin et autres
Supplementary Figs. 1-9
Accès ouvert
2023
supplementary-materials
OpenAlex
Il‐Kyu Kim, Choong‐Hyun Koh, Insu Jeon, Kwangsoo Shin et autres
Supplementary Figs. 1-9
2021
article
OpenAlex
Mungyo Jung, Mikyung Kang, Byung‐Seok Kim, Jihye Hong et autres
Despite the clinically proven efficacies of immune checkpoint blockades, including anti-cytotoxic T lymphocyte-associated protein 4 antibody (αCTLA-4), the low response rate and immune-related adverse events (irAEs) in cancer patients represent major drawbacks of the therapy. These drawbacks of αCTLA-4 therapy are mainly …
kr, Soudan
(code pays fourni par la source)
2021
article
OpenAlex
Jeong-Mi Lee, Kwangsoo Shin, Choong‐Hyun Koh, Boyeong Song et autres
kr, Éthiopie, pr
(code pays fourni par la source)